• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    VIVUS Inc. (VVUS)

    -NasdaqGS
    2.72 0.03(1.12%) Jan 27, 4:00PM EST
    Add to Portfolio
    Prev Close:2.69
    Open:2.64
    Bid:2.62 x 1000
    Ask:3.00 x 8700
    1y Target Est:3.30
    Beta:2.4
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:2.63 - 2.78
    52wk Range:2.56 - 7.73
    Volume:1,160,630
    Avg Vol (3m):2,165,670
    Market Cap:282.00M
    P/E (ttm):N/A
    EPS (ttm):-0.72
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VVUSUp 1.12%282.00M
    LLY76.72B
    GSK108.56B
    PFE205.40B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.04
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.81
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:3.3
    PEG Ratio (5 yr expected):-0.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback